Long-term survival of an adolescent glioblastoma patient under treatment with vinblastine and valproic acid illustrates importance of methylation profiling.
| Title: | Long-term survival of an adolescent glioblastoma patient under treatment with vinblastine and valproic acid illustrates importance of methylation profiling. |
|---|---|
| Authors: | Kresbach, Catena1,2 (AUTHOR), Bronsema, Annika1 (AUTHOR), Guerreiro, Helena3 (AUTHOR), Rutkowski, Stefan1 (AUTHOR), Schüller, Ulrich1,2,4 (AUTHOR), Winkler, Beate1 (AUTHOR) b.winkler@uke.de |
| Source: | Child's Nervous System. Feb2022, Vol. 38 Issue 2, p479-483. 5p. |
| Subject Terms: | *VALPROIC acid, *BRAIN tumors, *VINBLASTINE, *METHYLATION, *GLIOBLASTOMA multiforme, *TEENAGERS |
| Abstract: | Glioblastoma (GBM) is an exceptionally aggressive brain tumor with a dismal prognosis, demanding fast and precise classification as a base for patient-specific treatment strategies. Here, we report on an adolescent patient with a histologically bona fide GBM that shows a molecular methylation profile suggesting a low-grade glioma-like subgroup. Despite an early relapse, intolerance of temozolomide, and change of treatment strategy to vinblastine and valproic acid (VPA), the patient is now in good clinical condition after more than 5 years since initial diagnosis. This case stresses the merit of methylation array data for clinical prognosis and treatment planning. [ABSTRACT FROM AUTHOR] |
| Copyright of Child's Nervous System is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Academic Search Complete |
Be the first to leave a comment!